He joined the University of Colorado Denver as a postdoctoral researcher and then returned to conclude his clinical training as an infectious diseases specialist. Since 2008 he heads the division of Experimental Medicine, Department of Internal Medicine, Nijmegen University Nijmegen Medical Center.
Netea's field of study includes the innate immune system and its capacity to "memorize" infections, as well as its recognition of Fungi pathogens. He examined system's response to Candida albicans, a sepsis trigger. Additionally, he tried to search for genetic diseases that can make individuals more vulnerable to this type of infections.
Netea is known for his breakthrough in the area of Trained immunity. Netea's research attempts to translate information obtained through the assessment of human genetic variation in patients into novel diagnostic and therapeutic approaches.
2002: International Sepsis Forum Young Investigator Award
Publications
Peer-reviewed (selection)
M.G. Netea (1998). Modulation of proinflammatory cytokines (Thesis). Radboud University Nijmegen. 419 pp. hdl:2066/146584. ISBN90-90-11693-1.
Bekkering S, Arts RJW, ... , Stunnenberg H, Riksen NP, Netea MG. Metabolic Induction of Trained Immunity through the Mevalonate Pathway. Cell. 2018; 172: pages 135-146 (impact fact0r 28.7)
Mitroulis I, Ruppova K, Wang B, ... , Hajishengallis G, Netea MG, Chavakis T. Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Cell. 2018; 172: pages 147-161 (28.7).
Arts RJW, Moorlag SJCFM, Novakovic B, ... , Stunnenberg HG, van Crevel R, Netea MG. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe 2018; 23: paages 89-100 (13.4)
Ter Horst R, Jaeger M, Smeekens SP, ... , Wijmenga C, Notebaart RA, Joosten LA, Netea MG. Host and Environmental Factors Influencing Individual Human Cytokine Responses. Cell. 2016;167: pages 1111-1124 (28.7)
Li Y, Oosting M, Smeekens SP, Jaeger M, ... , Wijmenga C, Kumar V, Netea MG. A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans. Cell. 2016;167: pages 1099-1110 (28.7)
Schirmer M, Smeekens SP, Vlamakis H, ... , Wijmenga C, Netea MG, Xavier RJ. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell. 2016;167: pages 1125-1136 (28.7)
Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, O'Neill LA, Xavier RJ. Trained immunity: A program of innate immune memory in health and disease. Science. 2016 April 22;352(6284):aaf1098 (31.4)
Cheng SC, Brendon S, ... , van der Poll, Netea MG. Broad defects in energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nature Immunology, 2016, 17: pages 406-413 (21.7)
Li Y, Oosting M, Deelen P, Ricaño-Ponce I, Smeekens S, Jaeger M, Matzaraki V, Swertz MA, Xavier RJ, Franke L, Wijmenga C, Joosten LA, Kumar V, Netea MG. Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi. Nature Medicine. 2016 July 4. doi: 10.1038/nm.4139 (30)
Laayouni H, Oosting M, Luisi P, ... , Joosten LAB, Bertranpetit J, Netea MG. Convergent evolution in European and Rroma populations: pressure exerted by plague on Toll-like receptors. Proceedings of the National Academy of Sciences of the United States of America, 2014, 111: pages 2668-73 (9.8)
Lionakis M, Swamydas M, Fischer B, ..., Gao JL, Kullberg BJ, Netea MG, Murphy PM. Chemokine Receptor CX3CR1 Modulates Susceptibility to Systemic Candidiasis in Mice and Humans. Journal of Clinical Investigation 2013; 123(12): pages 5035-51 (13.9)
Smeekens SP, Ng A, ... van der Meer JW, Wijmenga C, Netea MG, Xavier RJ. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nature Communications 2013;4: page 1342 (10.0)
Kleinnijenhuis J, Quintin J, Preijers F, Joosten L.A.B., Ifrim DC, Saeed S, Jacobs C, van Loenhout J, de Jong D, Stunnenberg HG, Xavier RJ, van der Meer JWM, van Crevel R, Netea MG. BCG induces NOD2-dependent non-specific protection to reinfection via epigenetic reprogramming of monocytes. Proceedings of the National Academy of Sciences of the United States of America 2012, pages 17537-42 (9.4) 17. van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C, Arts P, Rosentul DC, Carmichael AJ, Smits-van der Graaf CA, Kullberg BJ, van der Meer JW, Lilic D, Veltman JA, Netea MG. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. The New England Journal of Medicine 2011 July 7;365(1): pages 54-61 (47)
Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe.19;9: pages 355-61. (13.4).
Bart Ferwerda, Gerben Ferwerda, Theo S. Plantinga, ... , Bart-Jan Kulberg, Gordon D. Brown, Netea MG. Human dectin-1 deficiency and mucocutaneous fungal infections The New England Journal of Medicine, 2009, 361;1760-7 (47)
Netea MG, Gow NA, Munro CA, ... , Van der Meer JW, Brown AJ, Kullberg BJ. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. Journal of Clinical Investigation 2006 June;116(6): pages 1642-50. (15.7)
Popular science
Netea, M. (2022). O istorie genetică (incompletă) a românilor [An (incomplete) genetic history of the Romanians] (in Romanian). Humanitas, Bucharest.
Science-fiction
Netea, M.G. (2015). North-West Passage to the Moon. CreateSpace Independent Publishing Platform, ISBN1515367398
Research grants
2002-2005 Junior researcher grant "The role of Toll-like receptors for recognition of Candida albicans" (250.000 euro)
2004-2009 Vidi Grant of the Netherlands Association for Scientific Research (600.000 euro).
2004-2007 Junior researcher grant "Pattern recognition receptors in disseminated candidiasis" (250.000 euro)
2007-2011 TI-Pharma consortium grant (500.000 euro).
2006-2009 Junior researcher grant "Adjuvants for Candida vaccination" (250.000 euro)
2006-2010 Diabetes Fonds grant "The role of interleukin-18 for glucose metabolism" (250.000 euro)
2008-2012 FIN-SysB Marie Curie grant (EU-FP7), for "Systems Biology of Candida albicans" (500.000 euro)
2009-2013 CTMM grant "Molecular Diagnosis and Risk Stratification of Sepsis (MARS)" (500.000 euro)
2009-2012 Junior researcher grant "Genetic susceptibility to invasive fungal infections" (250.000 euro)
2010-2015 Vici Grant of the Netherlands Association for Scientific Research (1.500.000 euro).
2011-2014 All-FUN research grant (EU-FP7), for "Immunology of Fungal Infections" (300.000 euro)
2012-2017 ERC Consolidator Grant, for Systems Biology of Fungal Infections (1.5 million euro)
2013-2018 CVON grant, "Gut microbiota and chronic inflammation as drivers of cardiovascular disease (1.100.000 euro)
2015-2019 TOP grant "The role of cellular metabolism of immune cells for the pathogenesis of sepsis" (337.000 euro)
2016-2019 REPROGRAM Horizon 2020 grant, on the role of trained immunity in cardiovascular diseases (900.000 euro)
2016-2020 Spinoza Prize for research on trained innate immunity (2.500.000 euro).
2016-2020 Collaborative Project Romanian Government for research on genomics in sepsis (2.000.000 euro)
2017-2021 HDHL-INTIMIC "Interrelation of the Intestinal Microbiome, Diet and Health" (400.000 euro)
Patents
EP2076282 – Novel antagonists of the Toll-like receptor 4.
EP6030245 - Novel method for diagnosing Lyme disease using a cellular immunological test (licensed)
EP6031158 – A novel method for diagnosing Q-fever using a cellular immunological test (licensed)
US14/760,604 – Galactosaminogalactan for use in the treatment of at least one inflammatory disease Filed November 2017 – Targeted nanoimunotherapy to increase trained immunity
↑Netea, Mihai; Ferwerda, Gerben; Van Der Graaf, Chantal; Van Der Meer, Jos W.; Kullberg, Bart Jan (November 2006). "Recognition of Fungal Pathogens by Toll-Like Receptors". Current Pharmaceutical Design. 12 (32): 4195–4201. doi:10.2174/138161206778743538. PMID17100622.[non-primary source needed]
↑Netea, Mihai G; van de Veerdonk, Frank L; van Deuren, Marcel; van der Meer, Jos WM (August 2011). "Defects of pattern recognition: primary immunodeficiencies of the innate immune system". Current Opinion in Pharmacology. 11 (4): 412–422. doi:10.1016/j.coph.2011.03.003. PMID21498117.[non-primary source needed]
↑Leentjens, Jenneke; Kox, Matthijs; Koch, Rebecca M.; Preijers, Frank; Joosten, Leo A. B.; van der Hoeven, Johannes G.; Netea, Mihai G.; Pickkers, Peter (November 2012). "Reversal of Immunoparalysis in Humans In Vivo: A Double-Blind, Placebo-controlled, Randomized Pilot Study". American Journal of Respiratory and Critical Care Medicine. 186 (9): 838–845. doi:10.1164/rccm.201204-0645OC. hdl:2066/109399. PMID22822024.[non-primary source needed]